Evidence of brain target engagement in Parkinson ’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials

Impaired brain energy metabolism has been observed in many neurodegenerative diseases, including Parkinson ’s disease (PD) and multiple sclerosis (MS). In both diseases, mitochondrial dysfunction and energetic ...

Source: Journal of Nanobiotechnology - December 13, 2023 Category: Nanotechnology Authors: Jimin Ren, Austin Rynders, Jacob Evan, Jeremy Evan, Shelia Ligozio, Karen S. Ho, Peter V. Sguigna, Robert Glanzman, Michael T. Hotchkin, Richard B. Dewey Jr. and Benjamin M. Greenberg Tags: Research Source Type: research